Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine
2008 ◽
Vol 20
(2)
◽
pp. 71-78
◽
2010 ◽
Vol 23
(5)
◽
pp. 742-748
◽
2018 ◽
Vol 12
(1)
◽
pp. 9-15
◽
2008 ◽
Vol 18
(4)
◽
pp. 381-383
◽
2016 ◽
Vol 26
(9)
◽
pp. 822-827
◽
2011 ◽
Vol 14
(6)
◽
pp. 777-786
◽
2009 ◽
Vol 29
(1)
◽
pp. 26-32
◽
Keyword(s):
2015 ◽
Vol 60
(10)
◽
pp. 441-450
◽